Long-Term One Year Use of Alefacept (Amevive) in Moderate to Severe Chronic Plaque Type Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Alefacept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 Aug 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.